Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cimdelirsen Phase 2 Study in Acromegaly
NCT03548415Phase 2Completed
- Sponsor
- Ionis Pharmaceuticals
- Start
- Sep 2018
- Primary completion
- Feb 2021
- Modality
- Modified DNA Oligonucleotides, Single-strand DNA, Antisense Oligonucleotides (ASOs)
- Countries
- 7
01
Overview
A Phase 2 trial of cimdelirsen in acromegaly, sponsored by Ionis Pharmaceuticals. Started Sep 2018; status: completed.
02
Drugs
cimdelirsen
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT03548415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03548415.